Weight loss tends to pick up speed after titrating to higher doses, and results typically keep building over the first twelve months
For tirzepatide, the incidence is slightly lower, ranging from 2.6% to 6.8% , depending on the dosage
These symptoms can point to something beyond routine digestive slowing, and your clinician may adjust your dose, slow your titration, or look for another cause
For some people, this can result in mild digestive symptoms such as nausea, constipation, or bloating
Research shows that large portion sizes often lead to consuming more calories despite not being hungry
What we know today comes from two sources: controlled clinical trials (STEP, SELECT, SURMOUNT) and the collective experience of over 1.5 million Americans using these medications as of January 2026